ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,881.63
      -0.43%
      US Tech 100
      20,449.60
      -0.85%
      Dow Jones
      42,544.22
      -0.07%
      Brent Oil
      75.125
      1.72%
      Bitcoin
      94,777.09
      0.41%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. Revive Therapeutics Ltd (QB) (RVVTF) Quote

      Revive Therapeutics Ltd (QB)

      Revive Therapeutics Ltd (QB) (RVVTF)

      USOTC
      0.0059
      -0.0008
      (-11.94%)
      Closed January 01 4:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.0059
      Bid
      0.0014
      Ask
      0.012
      Volume
      525,679
      0.005 Day's Range 0.0066
      0.005 52 Week Range 0.036
      Market Cap
      2.47M
      Previous Close
      0.0067
      Open
      0.005
      Last Trade
      1000
      @
      0.0059
      Last Trade Time
      Financial Volume
      $ 3,096
      VWAP
      0.005889
      Average Volume (3m)
      488,790
      Shares Outstanding
      418,564,269
      Dividend Yield
      -
      PE Ratio
      -5.97
      Earnings Per Share (EPS)
      -0.01
      Revenue
      -
      Net Profit
      -5.62M

      About Revive Therapeutics Ltd (QB)

      Sector
      Pharmaceutical Preparations
      Industry
      Unit Inv Tr, Closed-end Mgmt
      Website
      www.revivethera.com
      Headquarters
      Toronto, Ontario, Can
      Founded
      2014
      Revive Therapeutics Ltd (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker RVVTF. The last closing price for Revive Therapeutics (QB) was $0.01. Over the last year, Revive Therapeutics (QB) shares have traded in a share price range of $ 0.005 to $ 0.036.

      Revive Therapeutics (QB) currently has 418,564,269 shares outstanding. The market capitalization of Revive Therapeutics (QB) is $2.80 million. Revive Therapeutics (QB) has a price to earnings ratio (PE ratio) of -5.97.

      Ask ADVFN Intelligence (AI)

      RVVTF Latest News

      More News

      Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19

        Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19   TORONTO, Canada -- April 18, 2022 -- InvestorsHub NewsWire -- Revive...

      April 18 2022
      InvestorsHub NewsWire

      Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

        Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   TORONTO, Canada -- April 12, 2022 -- InvestorsHub NewsWire -- Revive...

      April 12 2022
      InvestorsHub NewsWire

      Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

      Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   Expected to seek DSMB approval to proceed with EUA application to the FDA in...

      March 29 2022
      InvestorsHub NewsWire

      HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

                                    HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive...

      February 24 2022
      InvestorsHub NewsWire

      Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation

       Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation  TORONTO, February 15, 2022 -- Revive...

      February 16 2022
      InvestorsHub NewsWire

      Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

      Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19Ethics Committee approval to proceed with Phase 3 clinical trial in Turkey13 clinical sites selected to...

      February 14 2022
      InvestorsHub NewsWire

      Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

      Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 701 subjects dosed to date Initiating enrollment activities in Turkey as part of its...

      January 19 2022
      InvestorsHub NewsWire

      Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

       Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film...

      January 17 2022
      InvestorsHub NewsWire

      Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19

       Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19 Approximately 700 subjects participated in the enrollment periodExpected to begin subject enrollment...

      January 07 2022
      InvestorsHub NewsWire

      Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant

       Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant TORONTO, November 16, 2021 -- InvestorsHub NewsWire -- Revive...

      November 16 2021
      InvestorsHub NewsWire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0002-3.278688524590.00610.00670.0054679930.00625405CS
      4-0.0012-16.90140845070.00710.00850.0055423280.00640692CS
      120.00011.724137931030.00580.0120.0054887900.00698507CS
      26-0.0011-15.71428571430.0070.01350.0053919830.00757598CS
      52-0.0116-66.28571428570.01750.0360.0053582500.01348438CS
      156-0.2601-97.78195488720.2660.390.0054404130.10881697CS
      260-0.03435-85.34161490680.040250.720.00510680690.27639465CS

      RVVTF - Frequently Asked Questions (FAQ)

      What is the current Revive Therapeutics (QB) share price?
      The current share price of Revive Therapeutics (QB) is $ 0.0059
      How many Revive Therapeutics (QB) shares are in issue?
      Revive Therapeutics (QB) has 418,564,269 shares in issue
      What is the market cap of Revive Therapeutics (QB)?
      The market capitalisation of Revive Therapeutics (QB) is USD 2.8M
      What is the 1 year trading range for Revive Therapeutics (QB) share price?
      Revive Therapeutics (QB) has traded in the range of $ 0.005 to $ 0.036 during the past year
      What is the PE ratio of Revive Therapeutics (QB)?
      The price to earnings ratio of Revive Therapeutics (QB) is -5.97
      What is the reporting currency for Revive Therapeutics (QB)?
      Revive Therapeutics (QB) reports financial results in CAD
      What is the latest annual profit for Revive Therapeutics (QB)?
      The latest annual profit of Revive Therapeutics (QB) is CAD -5.62M
      What is the registered address of Revive Therapeutics (QB)?
      The registered address for Revive Therapeutics (QB) is 82 RICHMOND STREET EAST, SUITE 105, TORONTO, ONTARIO, M5C 1P1
      What is the Revive Therapeutics (QB) website address?
      The website address for Revive Therapeutics (QB) is www.revivethera.com
      Which industry sector does Revive Therapeutics (QB) operate in?
      Revive Therapeutics (QB) operates in the UNIT INV TR, CLOSED-END MGMT sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      EWGFFEat Well Investment Group Inc (CE)
      $ 0.02
      (1,999,900.00%)
      		1.1k
      EHVVFEhave Inc (CE)
      $ 0.0075
      (749,900.00%)
      		7.03M
      RKFLRocketFuel Blockchain Inc (CE)
      $ 0.0011
      (109,900.00%)
      		4.2k
      EGRNFChina Evergrande Group (CE)
      $ 0.0102
      (101,900.00%)
      		9.3k
      TWOHTwo Hands Corporation (PK)
      $ 0.0008
      (79,900.00%)
      		1.65B
      HOILFHunter Technology Corporation (CE)
      $ 0.000001
      (-100.00%)
      		250
      GLGLFGLG Life Tech Corporation (CE)
      $ 0.000001
      (-99.99%)
      		6k
      NTACNew Technology Acquisition Holdings (CE)
      $ 0.000001
      (-99.75%)
      		6k
      RBSHRebus Holdings Inc (CE)
      $ 0.000001
      (-99.50%)
      		203k
      ZPASZoompass Holdings Inc (CE)
      $ 0.000001
      (-99.50%)
      		3k
      TWOHTwo Hands Corporation (PK)
      $ 0.0008
      (79,900.00%)
      		1.65B
      HCMCHealthier Choices Management Corporation (PK)
      $ 0.000001
      (0.00%)
      		224.2M
      HMBLHUMBL Inc (PK)
      $ 0.00085
      (-5.56%)
      		198.01M
      THBDThird Bench Inc (PK)
      $ 0.0001
      (-50.00%)
      		129.17M
      PHILPHI Group Inc (PK)
      $ 0.0003
      (-40.00%)
      		125.84M

      RVVTF Discussion

      View Posts
      govprs govprs 5 days ago
      Lol 
      👍️0
      rickstereo3333 rickstereo3333 6 days ago
      Things may look much better for Small Pharmacos with the new incoming admin (if they allow JFKs confirmation) because the playing field should be more equitable as opposed to the past.

      Hopefully Bucillamine will get looked over once again by the authorities as a potentially safe and effective multi use therapeutic for a host of maladies.

      AIMHOOC
      👍️ 1 🙏 1
      Classic Warrior Classic Warrior 4 weeks ago
      That's a relief. I'm down a few cents.
      👍️0
      KimKhaos5 KimKhaos5 4 weeks ago
      Shroom Boom. Psychedelic Therapy. 
      👍️0
      Milesblue42 Milesblue42 2 months ago
      NO PUMP....but a Crazy thought....

      1st this is in no way a PUMP Idea.

      2nd We don't know if RFK Jr will be confirmed. But just the mention of him being selected by DT sent a lot of BP stocks down.

      3rd if RFK Jr is confirmed somehow and his preference for more natural remedies would that make RVVTF finally attractive to BP?


      https://www.cnbc.com/2024/11/14/vaccine-maker-stocks-fall-as-trump-chooses-rfk-jr-to-lead-hhs.html
      👍️0
      Milesblue42 Milesblue42 2 months ago
      Ceo Frank being reported as well???

      Forward scamming trust bots to the SEC for making a stock appear to be a scam to newbies.

      Pure Comedy 😄
      👍️0
      cfoofme cfoofme 2 months ago
      Forward scamming trust bots to the SEC for making a stock appear to be a scam to newbies.
      👍️0
      TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
      Price prediction
      🥸 1
      TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
      Shareholders post
      🤓 1
      TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
      Speculating, wonder if market capitalization, miracle, if goes to billions , maybe fka billion
      👍️0
      TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
      Interesting stock price
      👍️0
      TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
      A lot of debt
      👍️0
      TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
      What makes you come up with $4
      👍️0
      Snoop_dog Snoop_dog 2 months ago
      $4 might finally be her JFK at the FDA.
      👍️0
      Snoop_dog Snoop_dog 2 months ago
      They should jump on it H5N1 next COVID.
      👍️0
      Snoop_dog Snoop_dog 2 months ago
      Any one knows if they work on H5N1?
      👍️0
      lolroflmao lolroflmao 2 months ago
      Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke Nov 12, 2024

      https://revivethera.com/2024/11/revive-therapeutics-announces-publication-demonstrating-novel-therapeutic-approach-of-psilocybin-in-stroke/
      👍️ 2 💥 1
      lolroflmao lolroflmao 2 months ago


      👍️0
      Ecomike Ecomike 2 months ago
      That dog is all bark and no bite. Ignore him
      👎️ 1
      Gatorca Gatorca 2 months ago
      Maybe another possibility If Buc. work 16x nac...Promising Role of N-Acetylcysteine in Reducing Airway Mucus in COPD Patients
      https://x.com/ThailandMedicaX/status/1851274249392308675
      Hopefully Cw, Rio seen his reply in reddit lol etc they get it to good Use instead of up mfs a ss Monthly 30k salary
      👍️0
      lolroflmao lolroflmao 2 months ago
      News: Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
      Oct 31, 2024

      https://revivethera.com/2024/10/revive-therapeutics-provides-update-on-research-study-evaluating-bucillamine-for-nerve-agent-exposure-2/
      👍️ 1
      TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
      One to watch
      👍️0
      TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
      0.0001
      👍️0
      TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
      Interesting company
      👍️0
      Gatorca Gatorca 3 months ago
      Derrick might be a better possible Ceo at this point with Shrooms lol ) what about the possible cancer fighting Shrooms?
      Ps. Sorry forgot the name of that shroom type possibility..
      Pss. Waiting on my Domino's lol..but not Mf. but honestlyhope eventuallyit works our Cw ops 5 shots pizza done heheh..
      👍️0
      Gatorca Gatorca 3 months ago
      I just hope 🙏 you ok
      👍️ 1
      Classic Warrior Classic Warrior 3 months ago
      Yea. It's my biggest loss, but I my optimism is all but gone. Mistakes were made for sure, but hopefully, the Canadian Department of Defense will see something in the drug and save the day. I still wonder what Derrick has been doing on the psychedelic side and the weed angle. What about those patented strips? I'd say we have about a 3% chance of recovery, but I have been wrong before and hope I am again.

      ps. Good luck, but profits elsewhere may be more realistic at this time.
      💯 1
      Gatorca Gatorca 3 months ago
      Just Sucks Cw all I can say now bucy good but Chit ceo etc...
      Maybe try some other stocks with some ot money
      Ps. Still trying to get it back Lol..but have good chance I think will see...
      👍️0
      JoeBenson JoeBenson 3 months ago
      Well you should know Giovanni, nobody has spewed more BS on this board than you have.
      👍️0
      Giovanni Giovanni 3 months ago
      All Is Fine was total BS.
      👍️ 2 💯 2
      JoeBenson JoeBenson 3 months ago
      "What false allegations did MF make?"

      👍️0
      Milesblue42 Milesblue42 3 months ago
      What do you mean? Explain please

      OMG .Oo7 how the long covid. The CEO needs to go to jail!!! Making false allegations about his product. Promises that never came true. Literally he should go to prison for financial fraud. Can't even hold a penny. MF I hope a bus comes by an pick you up. When we will get a new CEO. f joke. I hope he comes to Chicago we could show him the Chicago smile and the hospitality.

      What false allegations did MF make?
      👍️0
      Snoop_dog Snoop_dog 3 months ago
      OMG .Oo7 how the long covid. The CEO needs to go to jail!!! Making false allegations about his product. Promises that never came true. Literally he should go to prison for financial fraud. Can't even hold a penny. MF I hope a bus comes by an pick you up. When we will get a new CEO. f joke. I hope he comes to Chicago we could show him the Chicago smile and the hospitality.
      💯 1
      Snoop_dog Snoop_dog 3 months ago
      OMG .Oo7 how the long covid. The CEO needs to go to jail!!! Making false allegations about his product. Promises that never came true. Literally he should go to prison for financial fraud. Can't even hold a penny. MF I hope a bus comes by an pick you up. When we will get a new CEO. f joke. I hope he comes to Chicago we could show him the Chicago smile and the hospitality.
      👍️0
      powerbattles powerbattles 3 months ago
      Nobody cares and not enough volume to cover the cost issue of the news.
      👍️0
      lolroflmao lolroflmao 3 months ago
      NEWS: Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures

      SEP 18, 2024


      https://revivethera.com/2024/09/revive-therapeutics-announces-strategic-focus-on-bucillamine-for-infectious-diseases-and-medical-countermeasures/
      👍️ 1
      medicinecat medicinecat 4 months ago
      👍️ 1
      Hotel Delta Hotel Delta 4 months ago
      It'll go back up, buy now if you want to make a little money.
      👍️0
      mrfumbles mrfumbles 4 months ago
      Down down down
      👍️0
      govprs govprs 4 months ago
      Omg.
      👍️0
      JoeBenson JoeBenson 4 months ago
      👍️0
      Classic Warrior Classic Warrior 4 months ago
      Almost made back all the money I lost by working overtime, PB. I haven't sold a share but hope for a miracle. If I bought the same number of shares today, I'd own 50% of the company with MF.

      ps. more delays. Didn't see that coming although I'm not sure we can blame the big guy for that one. Monkeypox- here we come.
      👍️0
      powerbattles powerbattles 4 months ago
      Bucillamine showed promise, but MF is a con man. It's very sad to see that MF is taking advantage, he treats shareholders like ATMs to cover his personal expenses. I still see many loyal shareholders posting here. At this point, it's a choice between moving on or holding out for a miracle, which could still happen.
      👍️ 1
      Milesblue42 Milesblue42 4 months ago
      Bucillamine cures every Damn Thing

      Is this the Real Deal.....this time?

      Will Mr. Frank ever come through??
      👍️0
      stocktowatch stocktowatch 4 months ago
      $RVVTF Breaking News! Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections https://finance.yahoo.com/news/revive-therapeutics-provides-research-study-110000328.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via
      @YahooFinance
      👍️0
      Gatorca Gatorca 4 months ago
      Yes your right as fck....lol

      Ps. But bucillamine can work if the Ceo wasn't such a Dumb ass.....he just want his 30k salary what a piece of Chit yea fo Golfing fck investors his so Dumb .....
      👍️0
      MB1972 MB1972 4 months ago
      You and everyone else..MF stole all the money from the shareholders collecting a six figure salary and running this into the ground...only a miracle can get us out of this mess imo
      👍️ 1 💯 1
      govprs govprs 5 months ago
      You’re such a bag holder!!!!
      👍️0
      govprs govprs 5 months ago
      Investing in Rvvtf is like drinking tequila and puking hard


      MF is the biggest scam artist. If I could puke all over him right now I would
      👍️0
      medicinecat medicinecat 5 months ago
      Investing in RVVTF and drinking go together like peanut butter and jelly. Good luck my man.
      👍️ 1 💯 1

      Your Recent History

      USOTC
      RVVTF
      Revive Therapeutics (QB)
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads